Tenalisib Uses, Dosage, Side Effects and more
Tenalisib is under investigation in clinical trial NCT03711604 (Compassionate Use Study of Tenalisib (RP6530)).
| Trade Name | Tenalisib |
| Generic | Tenalisib |
| Tenalisib Other Names | Tenalisib |
| Type | |
| Formula | C23H18FN5O2 |
| Weight | Average: 415.428 Monoisotopic: 415.144453003 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
